Abstract:Marta Szukalska, 1 Bartosz F Grze&sacutekowiak, 2 Magdalena J Bigaj-Józefowska, 2 Marta Witkowska, 3, 4 Emilia Cicha, 5 Patrycja Sujka-Kordowska, 6 Izabela Miechowicz, 7 Micha&lstrok Nowicki, 6 Rados&lstrokaw Mrówczy&nacuteski, 3, 4 Ewa Florek 1 1 Laboratory of Environmental Research, Department of Toxicology, Poznan University of Medical Sciences, Pozna&nacute, Poland; 2 NanoBioMedical Centre, Adam Mickiewicz University, Pozna&nacute, Poland; 3 Faculty of Chemistry, Adam Mickiewicz University, Pozna&nacute, Poland; 4 Centre for Advanced Technologies, Adam Mickiewicz University, Pozna&nacute, Poland; 5 Laboratory of Experimental Animals, Poznan University of Medical Sciences, Pozna&nacute, Poland; 6 Department of Histology and Embryology, Poznan University of Medical Sciences, Pozna&nacute, Poland; 7 Department of Computer Science and Statistics, Poznan University of Medical Sciences, Pozna&nacute, Poland Correspondence: Marta Szukalska, Laboratory of Environmental Research, Department of Toxicology, Poznan University of Medical Sciences, Rokietnicka 3 Street, Poznan, 60-806, Poland, Email Purpose: Polydopamine nanoparticles (PDA NPs) have great potential in medicine. Their applications being widely investigated in cancer therapy, imaging, chemotherapy, photodynamic therapy (PDT), photothermal therapy (PTT), and tissue repair. The aim of our study was to assess the in vivo toxicity and changes in oxidative stress biomarkers in organs of animals treated with mesoporous PDA NPs modified with iron (MPDAFe NPs), coated with the cancer cell membrane and loaded with doxorubicin (DOX), and subsequently subjected to PTT. Methods: Liver and kidney homogenates were obtained from BALB/c nude mice with xenograft HepG2 human hepatoma cells, treated with iron modified mesoporous PDA nanoparticles, coated with the cancer cell membrane and loaded with doxorubicin (MPDAFe@DOX@Mem NPs), and subjected to PTT. These samples were used for histological evaluation and measurement of oxidative stress biomarkers, including total protein (TP), reduced glutathione (GSH), nitric oxide (NO), S-nitrosothiols (RSNO), thiobarbituric acid reactive substances (TBARS), trolox equivalent antioxidant capacity (TEAC), catalase (CAT), glutathione S-transferase (GST), and superoxide dismutase (SOD). Results: In the kidney, MPDAFe@DOX@Mem NPs in combination with PTT increased GSH (43%), TBARS (32%), and CAT (27%), while SOD decreased by 20% compared to the control group. Additionally, CAT activity in the liver increased by 79%. Conclusion: Significant differences in oxidative stress parameters and histological changes after administration with MPDAFe@DOX@Mem NPs and PTT were observed in the kidneys, showing more pronounced changes than the liver, indicating potential kidney toxicity. Our research provides insights into oxidative stress and possible toxic effects after in vivo administration of mesoporous PDA NPs combined with chemotherapy-photothermal therapy (CT-PTT), which is extremely important for their future applications in anticancer therapies. Keywords: polydopamine nanoparticles, oxidative stress, liver cancer model, in vivo toxicity, chemo- and photothermal therapy Graphical Polydopamine is a biopolymer obtained by polymerization of dopamine monomers, inspired by compounds used by mussels to stick to various surfaces. 1,2 Polydopamine nanoparticles have been of great interest to researchers for over fifteen years and have found a wide application in many areas of material chemistry, tissue engineering, implants, and nanomedicine. 3–7 The successful use of this biomimetic polymer to create various materials applied in medicine can be attributed to a set of unique physicochemical properties. The good adhesive properties of PDA allow it to cover virtually any type of material, including hydrophobic surfaces and various groups of nanoparticles and scaffolds. It is worth emphasizing that PDA is known to chelate almost all kinds of metals. This enables the attachment of paramagnetic metal ions to nanomaterials, providing them with contrast properties for MRI, which is particularly valuable for diagnostic approach. 6,8 Additionally, a wide range of PDA functionalization methods have been described for biomolecules and polymers for various applications. 6,7,9–11 The first major turning point for the role of polydopamine in nanomedicine was its use as a nanocarrier for drug delivery. 12 Thanks to its catechol, amine, and quinone groups, PDA can react with drugs b -Abstract Truncated-

Polydopamine Nanomaterials: Metal‐Containing Polydopamine Nanomaterials: Catalysis, Energy, and Theranostics (small 18/2020)

Metal-Containing Polydopamine Nanomaterials: Catalysis, Energy, and Theranostics.

Metal-chelated polydopamine nanomaterials: Nanoarchitectonics and applications in biomedicine, catalysis, and energy storage

Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine

Polydopamine-Based Nanoreactors: Synthesis And Applications In Bioscience And Energy Materials

Core-Shell Fe3o4 Polydopamine Nanoparticles Serve Multipurpose As Drug Carrier, Catalyst Support and Carbon Adsorbent

Interfacially responsive electron transfer and matter conversion by polydopamine-mediated nanoplatforms for advancing disease theranostics

Polydopamine-inspired Nanomaterials for Energy Conversion and Storage

Smart polydopamine-based nanoplatforms for biomedical applications: state-of-art and further perspectives

Polydopamine Based Colloidal Materials: Synthesis and Applications.

Polydopamine-based functional materials and their applications in energy, environmental, and catalytic fields: State-of-the-art review

Tunable, Metal-Loaded Polydopamine Nanoparticles Analyzed by Magnetometry

Role of Polydopamine’s Redox-Activity on Its Pro-Oxidant, Radical-Scavenging, and Antimicrobial Activities

Metal‐Coordinated Polydopamine Structures for Tumor Imaging and Therapy

Polydopamine Nanomaterials and Their Applications in Food Field

Metal-Polydopamine Frameworks and Their Transformation to Hollow Metal/N-Doped Carbon Particles

Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment

Polydopamine-based nanomaterials and their potentials in advanced drug delivery and therapy

Toxicity and Oxidative Stress Biomarkers in the Organs of Mice Treated with Mesoporous Polydopamine Nanoparticles Modified with Iron and Coated with Cancer Cell Membrane

Recent Advances on the Construction of Multidimensional Polydopamine-Based Nanostructures

Morphologically Controlled Bioinspired Dopamine‐Polypyrrole Nanostructures with Tunable Electrical Properties